Cancer Research Donn Young  Jordan
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Berking, C.
Right arrow Articles by Herlyn, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Berking, C.
Right arrow Articles by Herlyn, M.
[Cancer Research 61, 8306-8316, November 15, 2001]
© 2001 American Association for Cancer Research


Tumor Biology

Transforming Growth Factor-ß1 Increases Survival of Human Melanoma through Stroma Remodeling1

Carola Berking, Richelle Takemoto, Helmut Schaider, Louise Showe, Kapaettu Satyamoorthy, Paul Robbins and Meenhard Herlyn2

The Wistar Institute, Philadelphia, Pennsylvania 19104 [C. B., R. T., H. S., L. S., K. S., M. H.], and the University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania 15261 [P. R.]

Transforming growth factor (TGF)-ß is growth inhibitory for normal epithelial cells and melanocytes but can stimulate mesenchymal cells. Resistance to its inhibitory effects is characteristic of human melanoma, the growth of which may instead be promoted by TGF-ß, because its production is increased with melanoma progression. Whether TGF-ß has an autocrine function for melanoma cells or is important for paracrine stimulation of the tumor stroma is not known. In this study, TGF-ß1 was expressed in melanoma cells via adenoviral gene transfer, and tumor growth was analyzed in vitro, in human skin grafts, and in mixtures with fibroblasts that were injected s.c. into immunodeficient mice. The TGF-ß1 produced by the melanoma cells activated the fibroblasts to produce matrix within and around the tumor mass, whereas control tumors showed less stroma and more cell death. High expression of collagen, fibronectin, tenascin, and {alpha}2 integrin was detected in the TGF-ß1-expressing tumors by immunohistochemistry. Number and size of lung metastases were significantly increased. cDNA expression array analysis of TGF-ß1-transduced fibroblasts embedded in type I collagen and of TGF-ß1-transduced melanoma cells demonstrated induction of types XV, XVIII, and VI collagens, tenascin, plasminogen activator inhibitor-I, vascular endothelial growth factor, cysteine-rich fibroblast growth factor receptor-1, and platelet-derived growth factor receptor-ß, which could be linked to promotion of growth and survival in melanoma. These data suggest that remodeling of the neighboring stroma, which provides a supporting scaffolding and a positive feedback stimulation of tumor growth, is an important function of TGF-ß1 in melanoma.




This article has been cited by other articles:


Home page
Cancer Res.Home page
R. A. Rahimi, M. Andrianifahanana, M. C. Wilkes, M. Edens, T. J. Kottom, J. Blenis, and E. B. Leof
Distinct Roles for Mammalian Target of Rapamycin Complexes in the Fibroblast Response to Transforming Growth Factor-{beta}
Cancer Res., January 1, 2009; 69(1): 84 - 93.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
D. Javelaud, K. S. Mohammad, C. R. McKenna, P. Fournier, F. Luciani, M. Niewolna, J. Andre, V. Delmas, L. Larue, T. A. Guise, et al.
Stable Overexpression of Smad7 in Human Melanoma Cells Impairs Bone Metastasis
Cancer Res., March 1, 2007; 67(5): 2317 - 2324.
[Abstract] [Full Text] [PDF]


Home page
Molecular Cancer TherapeuticsHome page
Y. Sheffer, O. Leon, J. H. Pinthus, A. Nagler, Y. Mor, O. Genin, M. Iluz, N. Kawada, K. Yoshizato, and M. Pines
Inhibition of fibroblast to myofibroblast transition by halofuginone contributes to the chemotherapy-mediated antitumoral effect
Mol. Cancer Ther., February 1, 2007; 6(2): 570 - 577.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. N. Ivanov, Z. Ronai, and T. K. Hei
Opposite Roles of FAP-1 and Dynamin in the Regulation of Fas (CD95) Translocation to the Cell Surface and Susceptibility to Fas Ligand-mediated Apoptosis
J. Biol. Chem., January 20, 2006; 281(3): 1840 - 1852.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. N. Ivanov and T. K. Hei
Arsenite Sensitizes Human Melanomas to Apoptosis via Tumor Necrosis Factor {alpha}-mediated Pathway
J. Biol. Chem., May 21, 2004; 279(21): 22747 - 22758.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. Berking, R. Takemoto, K. Satyamoorthy, T. Shirakawa, M. Eskandarpour, J. Hansson, P. A. VanBelle, D. E. Elder, and M. Herlyn
Induction of Melanoma Phenotypes in Human Skin by Growth Factors and Ultraviolet B
Cancer Res., February 1, 2004; 64(3): 807 - 811.
[Abstract] [Full Text] [PDF]


Home page
Mol Cancer ResHome page
J. Huang, S. Z. Soffer, E. S. Kim, K. W. McCrudden, J. Huang, T. New, C. A. Manley, W. Middlesworth, K. O'Toole, D. J. Yamashiro, et al.
Vascular Remodeling Marks Tumors That Recur During Chronic Suppression of Angiogenesis
Mol. Cancer Res., January 1, 2004; 2(1): 36 - 42.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
E. S. Doubrovina, M. M. Doubrovin, E. Vider, R. B. Sisson, R. J. O'Reilly, B. Dupont, and Y. M. Vyas
Evasion from NK Cell Immunity by MHC Class I Chain-Related Molecules Expressing Colon Adenocarcinoma
J. Immunol., December 15, 2003; 171(12): 6891 - 6899.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
R. S. Muraoka, Y. Koh, L. R. Roebuck, M. E. Sanders, D. Brantley-Sieders, A. E. Gorska, H. L. Moses, and C. L. Arteaga
Increased Malignancy of Neu-Induced Mammary Tumors Overexpressing Active Transforming Growth Factor {beta}1
Mol. Cell. Biol., December 1, 2003; 23(23): 8691 - 8703.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
R. Castriconi, C. Cantoni, M. Della Chiesa, M. Vitale, E. Marcenaro, R. Conte, R. Biassoni, C. Bottino, L. Moretta, and A. Moretta
Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells
PNAS, April 1, 2003; 100(7): 4120 - 4125.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Dumont, A. V. Bakin, and C. L. Arteaga
Autocrine Transforming Growth Factor-beta Signaling Mediates Smad-independent Motility in Human Cancer Cells
J. Biol. Chem., January 24, 2003; 278(5): 3275 - 3285.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
D. P. Simmons, F. Andreola, and L. M. De Luca
Human melanomas of fibroblast and epithelial morphology differ widely in their ability to synthesize retinyl esters
Carcinogenesis, November 1, 2002; 23(11): 1821 - 1830.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Zheng and P. J. McKeown-Longo
Regulation of HEF1 Expression and Phosphorylation by TGF-beta 1 and Cell Adhesion
J. Biol. Chem., October 11, 2002; 277(42): 39599 - 39608.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2001 by the American Association for Cancer Research.